Participated · Equity · Oct 2025

Plasana Medical, born out of the Laboratoire de physique des plasmas of École polytechnique and the CNRS, is building Plasana One, a proprietary multi-jet cold-plasma device designed to stimulate tissue regeneration while limiting infection risk in chronic wounds such as diabetic foot ulcers, venous ulcers and pressure sores. The treatment is positioned to be six-to-twelve times faster and painless, targeting a 30–50 % reduction in healing time and enabling home-care use for the roughly 10 million patients affected in Europe and the United States. Backed by more than ten years of academic research and support from TechnoFounders, the company plans to complete its first French clinical trial (Plasana Genesis) and secure CE marking by 2026, followed by U.S. market entry. Commercial launch of its first product is expected within two years. Financially, Plasana has just secured €4 million in mixed financing (equity, grants and bank loans) to fund these milestones. No revenue or user metrics have been disclosed to date, and the company remains pre-commercial with its focus on product validation and regulatory clearance.

Participated · Equity · Apr 2024

KohortPay builds an in-checkout referral system that issues a shareable promo code to shoppers at the point of purchase; the code can be used by friends within seven days to unlock discounts and increase the buyer's reward. When a referred friend buys, the merchant reimburses the original buyer the agreed promotion directly to their bank card. The solution integrates on merchant sites in about three minutes and charges a fixed fee per buyer acquired plus a commission on the basket; merchants only pay if the solution generates customers. KohortPay targets large retailers and digital-native vertical brands and claims customer acquisition costs up to two times lower than campaigns on Google or Meta. Founded in early 2022 and described as a French ('tricolore') startup, it is led by co-founders Thomas Andrews and Martin Souriau. Short-term commercial objectives include signing around twenty contracts by June 2024; the company recently completed a €1.2M fundraising that includes part debt from Bpifrance.

Participated · Seed · May 2023

Zeliq is an all-in-one AI sales engagement platform providing precise prospect data and omnichannel outreach capabilities. The platform lets users explore a 450+ million prospect database, instantly add LinkedIn and Sales Navigator leads, sync CRM contacts, or upload CSV files. It enables outreach via phone calls, email sequences, and LinkedIn messages. Zeliq is already used by over 2,000 companies worldwide. The company intends to use the new funding to expand operations, broaden business reach, and accelerate development efforts. Zeliq was founded by Dorian Ciavarella and Guillaume Cruz and is based in Paris, France. Following the seed round, total funding to date stands at $15.4M. Zeliq is an AI-based sales solution provider that empowers sales teams with prospect data to automate customer acquisition. Its platform features auto-prospection—BDRs input an Ideal Customer Profile (ICP) and Zeliq’s enrichment AI generates lead lists tailored for higher conversion rates. The product offers an all-in-one dashboard to track sales activity across BDRs, and will include a LinkedIn plug-in and an email automator that integrates reminders and follow-ups into BDR workflows. The company is bringing its product to market and has acquired several hundred beta testers; the beta officially begins on 15 June 2023. Zeliq raised €5M in a Pre-Seed round and plans to use the funds to expand operations and development efforts. The company is led by CEO and Founder Dorian Ciavarella, CTO Victor Lennel, and COO Guillaume Cruz and is based in Paris, France.